Merck Earnings Estimate

MRK Stock

USD 83.01 1.41 1.67%

The next projected EPS of Merck is estimated to be 2.1278 with future projections ranging from a low of 1.96 to a high of 2.25. Merck's most recent 12-month trailing earnings per share (EPS TTM) is at 6.74. Please be aware that the consensus of earnings estimates for Merck Company is based on EPS before non-recurring items and includes expenses related to employee stock options.

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Merck is projected to generate 2.1278 in earnings per share on the 31st of March 2025. Merck earnings estimates show analyst consensus about projected Merck Company EPS (Earning Per Share). It derives the highest and the lowest estimates based on Merck's historical volatility. Many public companies, such as Merck, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Merck Revenue Breakdown by Earning Segment

By analyzing Merck's earnings estimates, investors can diagnose different trends across Merck's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is expected to rise to about 53.1 B this year, although the value of Pretax Profit Margin will most likely fall to 0.03.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Merck Earnings Estimation Breakdown

The calculation of Merck's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Merck is estimated to be 2.1278 with the future projection ranging from a low of 1.96 to a high of 2.25. Please be aware that this consensus of annual earnings estimates for Merck Company is based on EPS before non-recurring items and includes expenses related to employee stock options.

Last Reported EPS

1.72

1.96

Lowest

Expected EPS

2.1278

2.25

Highest

Merck Earnings Projection Consensus

Suppose the current estimates of Merck's value are higher than the current market price of the Merck stock. In this case, investors may conclude that Merck is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Merck's stock will quickly adjusts to the new information provided by the consensus estimate.

Number of Analysts	Historical Accuracy	Last Reported EPS		Estimated EPS for 31st of March 2025	Current EPS (TTM)
27	89.63%	1.72		2.1278	6.74

Merck Earnings History

Earnings estimate consensus by Merck Company analysts from Wall Street is used by the market to judge Merck's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Merck's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Merck Quarterly Gross Profit

12.58 Billion

Price Earnings Ratio is expected to rise to 735.88 this year, although the value of Retained Earnings will most likely fall to about 32.6 B. Net Income Applicable To Common Shares is expected to rise to about 17.5 B this year, although the value of Common Stock Shares Outstanding will most likely fall to about 2.7 B.

Hype

Prediction

Low	Estimated	High
81.14	82.83	84.52

Details

Intrinsic

Valuation

Low	Real	High
74.71	97.48	99.17

Details

Naive

Forecast

Low	Next	High
78.43	80.12	81.81

Details

28 Analysts

Consensus

Low	Target	High
116.23	127.73	141.78

Details

Note that many institutional investors and large investment bankers can move markets due to the volume of Merck assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Merck. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Merck's stock price in the short term.

Merck Earnings per Share Projection vs Actual

Actual Earning per Share of Merck refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Merck Company predict the company's earnings will be in the future. The higher the earnings per share of Merck, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Merck Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Merck, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Merck should always be considered in relation to other companies to make a more educated investment decision.

Merck Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Merck's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2025-02-04	2024-12-31	1.6651	1.72	0.0549	3
2024-10-31	2024-09-30	1.5	1.57	0.07	4
2024-07-30	2024-06-30	2.15	2.28	0.13	6
2024-04-25	2024-03-31	1.88	2.07	0.19	10
2024-02-01	2023-12-31	-0.11	0.03	0.14	127
2023-10-26	2023-09-30	1.95	2.13	0.18	9
2023-08-01	2023-06-30	-2.18	-2.06	0.12	5
2023-04-27	2023-03-31	1.32	1.4	0.08	6
2023-02-02	2022-12-31	1.54	1.62	0.08	5
2022-10-27	2022-09-30	1.71	1.85	0.14	8
2022-07-28	2022-06-30	1.7	1.87	0.17	10
2022-04-28	2022-03-31	1.83	2.14	0.31	16
2022-02-03	2021-12-31	1.53	1.8	0.27	17
2021-10-28	2021-09-30	1.55	1.75	0.2	12
2021-07-29	2021-06-30	1.31	1.31	0.0	0
2021-04-29	2021-03-31	1.63	1.4	-0.23	14
2021-02-04	2020-12-31	1.38	1.32	-0.06	4
2020-10-27	2020-09-30	1.44	1.74	0.3	20
2020-07-31	2020-06-30	1.04	1.37	0.33	31
2020-04-28	2020-03-31	1.34	1.5	0.16	11
2020-02-05	2019-12-31	1.15	1.16	0.01	0
2019-10-29	2019-09-30	1.24	1.51	0.27	21
2019-07-30	2019-06-30	1.16	1.3	0.14	12
2019-04-30	2019-03-31	1.06	1.22	0.16	15
2019-02-01	2018-12-31	1.03	1.04	0.01	0
2018-10-25	2018-09-30	1.14	1.19	0.05	4
2018-07-27	2018-06-30	1.03	1.06	0.03	2
2018-05-01	2018-03-31	1	1.05	0.05	5
2018-02-02	2017-12-31	0.94	0.98	0.04	4
2017-10-27	2017-09-30	1.03	1.11	0.08	7
2017-07-28	2017-06-30	0.87	1.01	0.14	16
2017-05-02	2017-03-31	0.83	0.88	0.05	6
2017-02-02	2016-12-31	0.89	0.89	0.0	0
2016-10-25	2016-09-30	0.99	1.07	0.08	8
2016-07-29	2016-06-30	0.91	0.93	0.02	2
2016-05-05	2016-03-31	0.85	0.89	0.04	4
2016-02-03	2015-12-31	0.91	0.93	0.02	2
2015-10-27	2015-09-30	0.91	0.96	0.05	5
2015-07-28	2015-06-30	0.81	0.86	0.05	6
2015-04-28	2015-03-31	0.75	0.85	0.1	13
2015-02-04	2014-12-31	0.85	0.87	0.02	2
2014-10-27	2014-09-30	0.88	0.9	0.02	2
2014-07-29	2014-06-30	0.81	0.85	0.04	4
2014-04-29	2014-03-31	0.79	0.88	0.09	11
2014-02-05	2013-12-31	0.89	0.88	-0.01	1
2013-10-28	2013-09-30	0.88	0.92	0.04	4
2013-07-30	2013-06-30	0.83	0.84	0.01	1
2013-05-01	2013-03-31	0.79	0.85	0.06	7
2013-02-01	2012-12-31	0.81	0.83	0.02	2
2012-10-26	2012-09-30	0.92	0.95	0.03	3
2012-07-27	2012-06-30	1.01	1.05	0.04	3
2012-02-02	2011-12-31	0.95	0.97	0.02	2
2011-10-28	2011-09-30	0.91	0.94	0.03	3
2011-07-29	2011-06-30	0.95	0.95	0.0	0
2011-04-29	2011-03-31	0.84	0.92	0.08	9
2011-02-03	2010-12-31	0.83	0.88	0.05	6
2010-10-29	2010-09-30	0.82	0.85	0.03	3
2010-07-30	2010-06-30	0.83	0.86	0.03	3
2010-05-04	2010-03-31	0.75	0.83	0.08	10
2010-02-16	2009-12-31	0.79	0.79	0.0	0
2009-10-22	2009-09-30	0.82	0.9	0.08	9
2009-07-21	2009-06-30	0.77	0.83	0.06	7
2009-04-21	2009-03-31	0.77	0.74	-0.03	3
2009-02-03	2008-12-31	0.74	0.87	0.13	17
2008-10-22	2008-09-30	0.79	0.8	0.01	1
2008-07-21	2008-06-30	0.83	0.86	0.03	3
2008-04-21	2008-03-31	0.86	0.89	0.03	3
2008-01-30	2007-12-31	0.74	0.8	0.06	8
2007-10-22	2007-09-30	0.69	0.75	0.06	8
2007-07-23	2007-06-30	0.72	0.82	0.1	13
2007-04-19	2007-03-31	0.84	0.84	0.0	0
2007-01-30	2006-12-31	0.5	0.5	0.0	0
2006-10-20	2006-09-30	0.5	0.51	0.01	2
2006-07-24	2006-06-30	0.65	0.73	0.08	12
2006-04-20	2006-03-31	0.72	0.78	0.06	8
2006-01-31	2005-12-31	0.62	0.64	0.02	3
2005-10-24	2005-09-30	0.62	0.65	0.03	4
2005-07-21	2005-06-30	0.62	0.62	0.0	0
2005-04-21	2005-03-31	0.59	0.62	0.03	5
2005-01-25	2004-12-31	0.5	0.5	0.0	0
2004-10-21	2004-09-30	0.71	0.6	-0.11	15
2004-07-21	2004-06-30	0.79	0.79	0.0	0
2004-04-22	2004-03-31	0.72	0.73	0.01	1
2004-01-27	2003-12-31	0.62	0.62	0.0	0
2003-10-22	2003-09-30	0.85	0.83	-0.02	2
2003-07-21	2003-06-30	0.84	0.83	-0.01	1
2003-04-21	2003-03-31	0.76	0.76	0.0	0
2003-01-28	2002-12-31	0.83	0.83	0.0	0
2002-10-18	2002-09-30	0.83	0.83	0.0	0
2002-07-19	2002-06-30	0.77	0.77	0.0	0
2002-04-18	2002-03-31	0.71	0.71	0.0	0
2002-01-22	2001-12-31	0.8	0.81	0.01	1
2001-10-18	2001-09-30	0.83	0.84	0.01	1
2001-07-20	2001-06-30	0.78	0.78	0.0	0
2001-04-20	2001-03-31	0.71	0.71	0.0	0
2001-01-23	2000-12-31	0.75	0.75	0.0	0
2000-10-20	2000-09-30	0.73	0.78	0.05	6
2000-07-24	2000-06-30	0.69	0.73	0.04	5
2000-04-24	2000-03-31	0.62	0.63	0.01	1
2000-01-26	1999-12-31	0.66	0.66	0.0	0
1999-10-21	1999-09-30	0.64	0.64	0.0	0
1999-07-23	1999-06-30	0.61	0.61	0.0	0
1999-04-23	1999-03-31	0.54	0.55	0.01	1
1999-01-26	1998-12-31	0.58	0.58	0.0	0
1998-10-16	1998-09-30	0.56	0.56	0.0	0
1998-07-21	1998-06-30	0.54	0.56	0.02	3
1998-04-16	1998-03-31	0.48	0.48	0.0	0
1998-01-27	1997-12-31	0.51	0.52	0.01	1
1997-10-16	1997-09-30	0.5	0.5	0.0	0
1997-07-17	1997-06-30	0.48	0.48	0.0	0
1997-04-16	1997-03-31	0.42	0.42	0.0	0
1997-01-28	1996-12-31	0.43	0.44	0.01	2
1996-10-16	1996-09-30	0.41	0.42	0.01	2
1996-07-18	1996-06-30	0.4	0.4	0.0	0
1996-04-17	1996-03-31	0.35	0.35	0.0	0
1996-01-23	1995-12-31	0.35	0.35	0.0	0

About Merck Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Merck earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Merck estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Merck fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'

Please read more on our stock advisor page.

	Last Reported	Projected for Next Year
Retained Earnings	62 B	32.6 B
Retained Earnings Total Equity	70.2 B	46 B
Price Earnings Ratio	700.84	735.88
Price Earnings To Growth Ratio	(9.18)	(8.72)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

How To Invest In Merck

Details

Is Merck Stock a good investment?

Details

What is Merck's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.33)

Dividend Share

3.08

Earnings Share

6.74

Revenue Per Share

25.253

Quarterly Revenue Growth

0.068

The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Merck Earnings Estimate

Merck Revenue Breakdown by Earning Segment

Merck Earnings Estimation Breakdown

Merck Earnings Projection Consensus

Merck Earnings History

Merck Quarterly Gross Profit

12.58 Billion

Merck Earnings per Share Projection vs Actual

Merck Estimated Months Earnings per Share

Merck Quarterly Analyst Estimates and Surprise Metrics

About Merck Earnings Estimate

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY